Related references
Note: Only part of the references are listed.Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: A case-control study
Emilia Balogh et al.
THROMBOSIS RESEARCH (2012)
Do Novel Risk Biomarkers Reflect the Severity of Peripheral Arterial Disease?
Nader Khandanpour et al.
ANGIOLOGY (2011)
Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties
Federico Cacciapuoti
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
A Field Synopsis and Meta-Analysis of Genetic Association Studies in Peripheral Arterial Disease: The CUMAGAS-PAD Database
Elias Zintzaras et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials
Charalambos Antoniades et al.
EUROPEAN HEART JOURNAL (2009)
Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis
Nader Khandanpour et al.
JOURNAL OF VASCULAR SURGERY (2009)
Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: The Linz Peripheral Arterial Disease (LIPAD) Study
T Mueller et al.
JOURNAL OF VASCULAR SURGERY (2005)
Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia
G Ravaglia et al.
EXPERIMENTAL GERONTOLOGY (2004)
Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients
E Ciccarone et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patients
H Darius et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
B vitamin status and inflammatory markers
AR Folsom et al.
ATHEROSCLEROSIS (2003)
Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease
RS Dieter et al.
VASCULAR MEDICINE (2003)
Novel risk factors for peripheral arterial disease in young women
DGM Bloemenkamp et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Homocysteine, vitamins and gene mutations in peripheral arterial disease
H Stricker et al.
BLOOD COAGULATION & FIBRINOLYSIS (2001)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis
TJ Cleophas et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)
Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: The Hoorn Study
EK Hoogeveen et al.
JOURNAL OF INTERNAL MEDICINE (2000)
Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh artery study
FGR Fowkes et al.
ATHEROSCLEROSIS (2000)
Share Paper
